High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma

NCT00002763 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1000

Enrollment

NETWORK

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: recombinant interferon alfa

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC